{"id":"W4408549696","doi":"10.1111/cas.16459","title":"Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration‐Resistant Prostate Cancer: <scp>PROpel</scp> Subset Analysis","year":2025,"lang":"en","type":"article","venue":"Cancer Science","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"AstraZeneca","keywords":"Olaparib; Medicine; Placebo; Clinical endpoint; Hazard ratio; Prostate cancer; Internal medicine; Population; Abiraterone; Oncology; Confidence interval; Abiraterone acetate; Urology; Cancer; Clinical trial; Androgen deprivation therapy; Pathology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004259512,0.0002506814,0.000523288,0.0009178198,0.000277357,0.000162382,0.0003262523,0.00003880659,0.00005347462],"category_scores_gemma":[0.00007949481,0.0001699487,0.00006622318,0.006920791,0.0007249367,0.0004356041,0.00008532896,0.0002403213,0.000007266232],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001610726,"about_ca_system_score_gemma":0.003873044,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002293848,"about_ca_topic_score_gemma":0.006183527,"domain_scores_codex":[0.9971362,0.00005416379,0.0003692672,0.0007701056,0.0009010028,0.0007692667],"domain_scores_gemma":[0.9985437,0.00004340629,0.000132587,0.0004598533,0.0005557265,0.000264726],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006488336,0.0003223727,0.9792404,0.0002756183,0.0006025444,0.0001032257,0.002448468,0.001656459,0.004397568,0.000118221,0.000503535,0.009682788],"study_design_scores_gemma":[0.00593689,0.0004137599,0.9786877,0.0003772523,0.000691748,9.194741e-7,0.0006401013,0.00156179,0.01057356,0.00004401918,0.0009504816,0.0001217846],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930761,0.00210535,0.0000835273,0.001186824,0.0001710824,0.00128169,0.0001742477,0.00003845424,0.001882653],"genre_scores_gemma":[0.9937776,0.0004183555,0.0003431301,0.0002220574,0.0000192367,0.0005415838,0.00006896452,0.00001469677,0.004594394],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009561003,"threshold_uncertainty_score":0.6930308,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01769336179378932,"score_gpt":0.3220274687171265,"score_spread":0.3043341069233371,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}